Brookings Report Examines Private Sector Investments In Health R&D Dedicated To Developing Countries

Brookings Institution’s “TechTank”: Less than four percent of private investment in health R&D targets the developing world
Liz Sablich, director of communications for governance studies at Brookings, discusses findings from a report on private sector investments in overall health R&D, which found “an exceedingly small share was dedicated to the developing world,” and highlights recommendations to improve private investment in global health drugs and vaccines (4/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.